No Data
No Data
TD Cowen Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $100
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $105
Citi Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $104
DexCom Names Jon Coleman as Chief Commercial Officer
Express News | Dexcom Appoints Jon Coleman as Chief Commercial Officer
150000 US dollars : Ah, me too, I look at it every day, but I have not placed an order.
103517607 150000 US dollars : Me too haha!